Literature DB >> 12709019

The influence of macrophage inflammatory protein-1alpha on protective immunity mediated by antiviral cytotoxic T cells.

Emma Jones1, David A Price, Michaela Dahm-Vicker, Vincenzo Cerundolo, Paul Klenerman, Awen Gallimore.   

Abstract

Macrophage inflammatory protein 1alpha (MIP-1alpha), a member of the CC-chemokine subfamily, is known to induce chemotaxis of a variety of cell types in vivo. Although the role of MIP-1alpha in inflammatory responses generated following primary infection of mice with many different pathogens has been characterized, the influence of this chemokine on the generation of antigen-specific T-cell responses in vivo is less well understood. This is important, as virus-specific CD8+ T lymphocytes (CTL) play a crucial role in defence against viral infections, both acutely and in the long term. In this study, we compared the ability of wild-type and MIP-1alpha-deficient (MIP-1alpha-/-) mice to mount CTL responses specific for the immunodominant epitope derived from influenza nucleoprotein (NP366-374). Influenza-specific CTL responses were compared with respect to frequency, cytotoxic activity and ability to clear subsequent infections with recombinant vaccinia viruses expressing the influenza NP. The results indicate that antiviral CTL generated in MIP-1alpha-/- mice are slightly impaired in their ability to protect against a subsequent infection. However, impaired in vivo CTL-mediated antiviral protection was found to be associated with reduced cytotoxicity rather than with a failure of the CTL to migrate to peripheral sites of infection.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12709019      PMCID: PMC1782947          DOI: 10.1046/j.1365-2567.2003.01636.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  42 in total

1.  Preferential localization of effector memory cells in nonlymphoid tissue.

Authors:  D Masopust; V Vezys; A L Marzo; L Lefrançois
Journal:  Science       Date:  2001-03-01       Impact factor: 47.728

Review 2.  Chemokines and cell migration in secondary lymphoid organs.

Authors:  J G Cyster
Journal:  Science       Date:  1999-12-10       Impact factor: 47.728

3.  Two subsets of memory T lymphocytes with distinct homing potentials and effector functions.

Authors:  F Sallusto; D Lenig; R Förster; M Lipp; A Lanzavecchia
Journal:  Nature       Date:  1999-10-14       Impact factor: 49.962

4.  Anti-viral protection and prevention of lymphocytic choriomeningitis or of the local footpad swelling reaction in mice by immunization with vaccinia-recombinant virus expressing LCMV-WE nucleoprotein or glycoprotein.

Authors:  M Hany; S Oehen; M Schulz; H Hengartner; M Mackett; D H Bishop; H Overton; R M Zinkernagel
Journal:  Eur J Immunol       Date:  1989-03       Impact factor: 5.532

5.  A chemokine-to-cytokine-to-chemokine cascade critical in antiviral defense.

Authors:  T P Salazar-Mather; T A Hamilton; C A Biron
Journal:  J Clin Invest       Date:  2000-04       Impact factor: 14.808

6.  Inducible expression of inflammatory chemokines in respiratory syncytial virus-infected mice: role of MIP-1alpha in lung pathology.

Authors:  H A Haeberle; W A Kuziel; H J Dieterich; A Casola; Z Gatalica; R P Garofalo
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

7.  Naive, effector, and memory CD8 T cells in protection against pulmonary influenza virus infection: homing properties rather than initial frequencies are crucial.

Authors:  A Cerwenka; T M Morgan; R W Dutton
Journal:  J Immunol       Date:  1999-11-15       Impact factor: 5.422

8.  T-lymphocyte production of macrophage inflammatory protein-1alpha is critical to the recruitment of CD8(+) T cells to the liver, lung, and spleen during graft-versus-host disease.

Authors:  J S Serody; S E Burkett; A Panoskaltsis-Mortari; J Ng-Cashin; E McMahon; G K Matsushima; S A Lira; D N Cook; B R Blazar
Journal:  Blood       Date:  2000-11-01       Impact factor: 22.113

9.  Thymic depletion and peripheral activation of class I major histocompatibility complex-restricted T cells by soluble peptide in T-cell receptor transgenic mice.

Authors:  C Mamalaki; T Norton; Y Tanaka; A R Townsend; P Chandler; E Simpson; D Kioussis
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-01       Impact factor: 11.205

10.  CD4(+) T cell subsets during virus infection. Protective capacity depends on effector cytokine secretion and on migratory capability.

Authors:  K J Maloy; C Burkhart; T M Junt; B Odermatt; A Oxenius; L Piali; R M Zinkernagel; H Hengartner
Journal:  J Exp Med       Date:  2000-06-19       Impact factor: 14.307

View more
  12 in total

1.  Pathogenesis, Host Innate Immune Response, and Aerosol Transmission of Influenza D Virus in Cattle.

Authors:  Elias Salem; Sara Hägglund; Hervé Cassard; Tifenn Corre; Katarina Näslund; Charlotte Foret; David Gauthier; Anne Pinard; Maxence Delverdier; Siamak Zohari; Jean-François Valarcher; Mariette Ducatez; Gilles Meyer
Journal:  J Virol       Date:  2019-03-21       Impact factor: 5.103

2.  Role of host cytokine responses in the pathogenesis of avian H5N1 influenza viruses in mice.

Authors:  Kristy J Szretter; Shivaprakash Gangappa; Xuihua Lu; Chalanda Smith; Wun-Ju Shieh; Sherif R Zaki; Suryaprakash Sambhara; Terrence M Tumpey; Jacqueline M Katz
Journal:  J Virol       Date:  2006-12-20       Impact factor: 5.103

Review 3.  Role of chemokines in regulation of immunity against leishmaniasis.

Authors:  Steve Oghumu; Claudio M Lezama-Dávila; Angelica P Isaac-Márquez; Abhay R Satoskar
Journal:  Exp Parasitol       Date:  2010-03-03       Impact factor: 2.011

4.  Early control of H5N1 influenza virus replication by the type I interferon response in mice.

Authors:  Kristy J Szretter; Shivaprakash Gangappa; Jessica A Belser; Hui Zeng; Hualan Chen; Yumiko Matsuoka; Suryaprakash Sambhara; David E Swayne; Terrence M Tumpey; Jacqueline M Katz
Journal:  J Virol       Date:  2009-03-18       Impact factor: 5.103

5.  TLR9 agonist, but not TLR7/8, functions as an adjuvant to diminish FI-RSV vaccine-enhanced disease, while either agonist used as therapy during primary RSV infection increases disease severity.

Authors:  Teresa R Johnson; Srinivas Rao; Robert A Seder; Man Chen; Barney S Graham
Journal:  Vaccine       Date:  2009-04-03       Impact factor: 3.641

6.  Interleukin-6 limits influenza-induced inflammation and protects against fatal lung pathology.

Authors:  Sarah N Lauder; Emma Jones; Kathryn Smart; Anja Bloom; Anwen S Williams; James P Hindley; Beatrice Ondondo; Philip R Taylor; Mathew Clement; Ceri Fielding; Andrew J Godkin; Simon A Jones; Awen M Gallimore
Journal:  Eur J Immunol       Date:  2013-08-12       Impact factor: 5.532

7.  Different maturation cocktails provide dendritic cells with different chemoattractive properties.

Authors:  Chiara Massa; Carolin Thomas; Ena Wang; Francesco Marincola; Barbara Seliger
Journal:  J Transl Med       Date:  2015-06-03       Impact factor: 5.531

8.  Avidity of influenza-specific memory CD8+ T-cell populations decays over time compromising antiviral immunity.

Authors:  Ian R Humphreys; Mathew Clement; Morgan Marsden; Kristin Ladell; James E McLaren; Kathryn Smart; James P Hindley; Hayley M Bridgeman; Hugo A van den Berg; David A Price; Ann Ager; Linda Wooldridge; Andrew Godkin; Awen M Gallimore
Journal:  Eur J Immunol       Date:  2012-10-16       Impact factor: 5.532

9.  Interleukin-6 is crucial for recall of influenza-specific memory CD4 T cells.

Authors:  Maria Paula Longhi; Kate Wright; Sarah N Lauder; Mari A Nowell; Gareth W Jones; Andrew J Godkin; Simon A Jones; Awen M Gallimore
Journal:  PLoS Pathog       Date:  2008-02-29       Impact factor: 6.823

10.  L-selectin Is Essential for Delivery of Activated CD8(+) T Cells to Virus-Infected Organs for Protective Immunity.

Authors:  Rebar N Mohammed; H Angharad Watson; Miriam Vigar; Julia Ohme; Amanda Thomson; Ian R Humphreys; Ann Ager
Journal:  Cell Rep       Date:  2016-01-21       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.